Multimodal Analysis of Endomyocardial Biopsies

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to pursue a multimodal approach to identify the molecular signatures and immune signalling molecules of various myocardial diseases and thereby contribute to improving diagnosis and therapy. The main aim is: -Identification of molecular profiles (e.g., proteome, lipidome, metabolome) and immune signalling profiles that are specifically associated with different myocardial diseases and the post-heart transplantation course. Participants already receiving an endomyocardial biopsy as part of their regular medical care will be enrolled. An additional biopsy sample will be taken for the above mentioned research.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged \>18 years with a clinical indication for endomyocardial biopsy.

• Patients capable of providing informed consent who have signed the consent form for participation in the study.

Locations
Other Locations
Germany
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University Hospital Essen, Germany
RECRUITING
Essen
Contact Information
Primary
Lars Michel, PD Dr. med.
lars.michel@uk-essen.de
+49 0201 723 84841
Time Frame
Start Date: 2025-10-27
Estimated Completion Date: 2028-09-30
Participants
Target number of participants: 216
Treatments
Patients undergoing endomyocardial biopsy following clinical indication
All patients with a clinical indication for EMB without regard to certain disease types. Typically these patients are after heart transplantation, amyloidosi or with a cardiomyopathy, including dilated-, hypertrophic- or inflammatory cardiomyopathy.
Sponsors
Leads: University Hospital, Essen

This content was sourced from clinicaltrials.gov